Dirk Schwabe

Treatment of patients with advanced cancer with the natural killer cell line NK-92

Torsten Tonn, Dirk Schwabe, Hans Klingemann et al. · Cytotherapy · 2013 · 471 citations

Life Sciences, Immunology, Oncology +12

Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97

Barbara Hero, Thorsten Simon, Ruediger Spitz et al. · Journal of Clinical Oncology · 2008 · 308 citations

Medicine, Oncology, Pediatrics +15

Prospective Evaluation of the Thrombotic Risk in Children With Acute Lymphoblastic Leukemia Carrying the MTHFR TT 677 Genotype, the Prothrombin G20210A Variant, and Further Prothrombotic Risk Factors

Ulrike Nowak‐Göttl, C. Wermes, Ralf Junker et al. · Blood · 1999 · 196 citations

Medicine, Genetics, Hematology +17

Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history ofMYH9-related disease

Alessandro Pecci, Emanuele Panza, Núria Pujol‐Moix et al. · Human Mutation · 2007 · 185 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers

M. Stern, Jakob Passweg, Sandrine Meyer‐Monard et al. · Bone Marrow Transplantation · 2012 · 173 citations

Life Sciences, Immunology, Oncology +16